Clinical Characteristics and Treatment Outcomes of Severe Asthma Patients with a History of Multiple Biologic Drugs Use

Clinical Characteristics and Treatment Outcomes of Severe Asthma Patients with a History of Multiple Biologic Drugs Use - Clinical Characteristics and Treatment Outcomes of Severe Asthma Patients with a History of Multiple Biologic Drugs Use

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000043274

Enrollment

105

Registered

2021-02-07

Start date

2020-05-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Severe asthma patients (equivalent to guideline steps 4 or 5, according 18 to the Global Initiative for Asthma 2019) who received biologic drug for the treatment of asthma

Exclusion criteria

Exclusion criteria: History of immunodeficiency or malignancy

Design outcomes

Primary

Measure	Time frame
Change of asthma control test after the latest biologic drug use.	—

Secondary

Measure	Time frame
Annual exacerbation rate, oral corticosteroid dose	—

Countries

Japan

Contacts

Public ContactAkaba Tomohiro

Tokyo Women's Medical University Department of respiratory medicine

akaba.tomohiro@twmu.ac.jp03-3353-8111

Outcome results